e-learning
resources
ERJ
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Pulmonary hypertension associated with left heart disease: efforts to improve the meaning of haemodynamic phenotypes
Christian Gerges, Mario Gerges, Irene M. Lang
Source:
Eur Respir J, 53 (3) 1802393; 10.1183/13993003.02393-2018
Journal Issue:
March
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Christian Gerges, Mario Gerges, Irene M. Lang. Pulmonary hypertension associated with left heart disease: efforts to improve the meaning of haemodynamic phenotypes. Eur Respir J, 53 (3) 1802393; 10.1183/13993003.02393-2018
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Optimizing invasive ventilation for SMA type 1 children who are receiving the gene therapy
Panel discussion on acute decompensated pulmonary hypertension
The definition of pulmonary hypertension: history, practical implications and current controversies
Related content which might interest you:
Haemodynamics to predict outcome in pulmonary hypertension due to left heart disease: a meta-analysis
Source: Eur Respir J, 51 (4) 1702427; 10.1183/13993003.02427-2017
Year: 2018
Clinical phenotypes and outcomes of pulmonary hypertension due to left heart disease: role of the pre-capillary component
Source: International Congress 2017 – Outcomes and new treatment strategies in pulmonary hypertension
Year: 2017
Under pressure: pulmonary hypertension associated with left heart disease
Source: Eur Respir Rev 2015; 24: 665-673
Year: 2015
How to define pulmonary hypertension due to left heart disease
Source: Eur Respir J 2016; 48: 553-555
Year: 2016
Pulmonary hypertension associated with left heart disease
Source: Eur Respir Mon 2012; 57: 119-137
Year: 2012
Pulmonary arterial hypertension or left heart disease with pulmonary hypertension? Toward noninvasive clarity, but time for a new paradigm
Source: Eur Respir J 2015; 46: 299-302
Year: 2015
The haemodynamic and gas-exchange responses to exercise in pulmonary hypertension, chronic obstructive pulmonary disease and left heart ventricle failure: similarities and differences
Source: International Congress 2018 – Integrated care for patients with pulmonary vascular disease, lung diseases and heart failure
Year: 2018
Beta-blockers in pulmonary arterial hypertension: evolving concepts of right heart failure
Source: Eur Respir J 2015; 46: 619-621
Year: 2015
Prognostic factors in pulmonary arterial hypertension: assessing the course of the disease
Source: Eur Respir Rev 2011; 20: 236-242
Year: 2011
Pulmonary hypertension due to left heart disease
Source: Eur Respir J, 53 (1) 1801897; 10.1183/13993003.01897-2018
Year: 2019
Relation between hemodynamics and right ventricular hypertrophy may affect survival and severity of the disease in patients with primary pulmonary hypertension (PPH)
Source: Eur Respir J 2002; 20: Suppl. 38, 26s
Year: 2002
Pulmonary vascular gradient: A predictor of prognosis in pulmonary hypertension due to left heart disease
Source: Annual Congress 2012 - Pulmonary circulation: end-points and biomarkers
Year: 2012
Spontaneous haemodynamic variability during right heart catetherisation in patients with pulmonary hypertension
Source: Annual Congress 2010 - Pulmonary vascular diseases
Year: 2010
Does left heart disease cause most systemic sclerosis associated pulmonary hypertension?
Source: Eur Respir J 2013; 42: 888-890
Year: 2013
Optimising pharmacotherapy in patients with pulmonary arterial hypertension and comorbidities, including lung diseases and heart failure: benefits without harm?
Source: International Congress 2018 – Integrated care for patients with pulmonary vascular disease, lung diseases and heart failure
Year: 2018
In-depth haemodynamic phenotyping of pulmonary hypertension due to left heart disease
Source: Eur Respir J, 51 (5) 1800067; 10.1183/13993003.00067-2018
Year: 2018
Impaired cardiac autonomic control relates to disease severity in pulmonary hypertension
Source: Eur Respir J 2009; 34: 895-901
Year: 2009
Bosentan treatment for pulmonary arterial hypertension related to congenital heart disease: real-world clinical experience in Spain
Source: Annual Congress 2009 - Pulmonary hypertension
Year: 2009
Prognostic value of right ventricular function in patients with severe pulmonary hypertension associated with respiratory disease
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept